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Abstract 
Background: As the hippocampus is the main brain region for many forms of learning and 
memory functions and is acutely sensitive to blood glucose changes, diabetes mellitus (DM); 
which is a serious metabolic disease; is often accompanied by learning and memory deficits. 
Through scientific literatures, mesenchymal stem cells (MSCs) promote functional recovery in 
rats with traumatic brain injury, so the present work was conducted to study MSCs as a possible 
treatment for the diabetic neuronal degeneration and functional impairment of rat hippocampus. 
Material and methods: It was carried out using male albino rats; non-diabetic control groups (4, 
8, 12 weeks) (n= 15), diabetic groups by i.v. injection of streptozotocin (STZ) for (4, 8, 12 weeks) 
(n= 15) and MSCs treatment to diabetic groups for (8, 12 weeks) (n= 10). Hippocampal learning 
and memory functions were assessed by the Morris Water Maze test (MWM) and its results were 
statistically analyzed. The rat hippocampal regions (CA1 and CA3) were subjected to histological, 
ultrastructural examination and morphmetrical analyze of pyramidal neurons.  
Results: Neurons of the diabetic groups showed disturbed function and architecture; shrunken 
hyperchromatic nuclei and vacuolated eosinophilic cytoplasm (apoptotic changes) also MSCs 
treatment improved hippocampal learning and memory functions plus its architectural changes; 
increasing populations and normal regular distribution.  
Conclusions: It can be concluded that diabetic hippocampal neuronal alternations and functional 
impairment can be ameliorated by MSCs treatment. 
Key words: diabetes, mesenchymal stem cells, hippocampus, neuronal alternations, learning 
and memory 
 
 
Introduction  
Uncontrolled DM leads to severe complications of central nervous system usually 
associated with neuronal degeneration [31]. As the hippocampus is particularly sensitive to 
changes in blood glucose level specially CA1 and CA3 regions [21], DM produces hippocampal 
dysfunction that is involved in learning and memory processing enhancing the risk of Alzheimer’s 
disease [3]. Through scientific literature, DM can affect the hippocampus through reducing its 
synaptic plasticity [22], changes glutamate neurotransmission [10] and augments enzymatic 
activity linked to oxidative stress in the hippocampus [29]. These changes are usually associated 
with sings of neuronal loss and apoptosis which are due to stimulation of caspase-3 activity, 
nuclear DNA cleavage and induction of proapoptotic genes in hippocampus especially with 
uncontrolled DM [19]. As STZ can cause pancreatic β-cell destruction, it is used experimentally to 
induce type 1 DM [17]. MSCs have been used experimentally in the treatment of the injured brain 
[1, 6, 11] as well as other damaged organs as in kidney [9], heart, etc. In the reviewed literatures 
there was obvious contradiction concerning the differention of MSCs into the functioning nerve 
cells. Several studies showed that MSCs transplanted into the intact, injured or diseased CNS 
environments do not differentiate or even a small portion of them produce neural phenotypes [8]. 
Even though, Chopp [6] demonstrated that, transplanted MSCs promote functional recovery in 
rats with traumatic brain injury through activation of endogenous angiogenesis, neurogenesis, and 
synaptogenesis. Moreover, other studies supported that; MSCs could differentiate into mature 
neuron-like cells and exhibiting neuronal properties [1, 11]. Also, Calió [4] discussed MSCs role 
on the injured brain by decreasing neuronal apoptosis and oxidative stress. The aim of the present 
work was to evaluate using MSCs as a possible treatment for diabetic neuronal degeneration and 
learning and memory alternations.  
 
Material and methods 
Mesenchymal stem cells preparation: MSCs were obtained from Medical biochemistry 
department, Faculty of Medicine, Cairo University. Bone marrow derived mesenchymal stem cells 
was isolated and cultivated for four weeks according to protocol of Jiang [13]. Next, cells were 
labeled with 5-bromo- 2ʹ-deoxyuridine (BrdU). Fluorescence phase-contrast microscope 
(Axiocam MR R3, Carl Zeiss, Germany) was used to observe the rats mesenchymal stem cells 
every 2 or 3 days. 
Animals: The experiment strictly adhered to all ethical guidelines regarding animal 
research and was approved by the Institutional Animal Care and Use Committee of Cairo 
University (CU-IACUC). Adult normoglycemic male Sprague-Dawley albino rats (150-200g) 
were used in the current study. Rats were kept in a temperature and humidity-controlled room, 
with free access to food and water and were placed 5/cadge.  
Experimental design: The rats were divided into 3 groups: Control group (n=15) which 
was subdivided into 3 subgroups (n=5/subgroup) [20]: (Control 4wks: sacrificed after 4 weeks, 
Control 8wks: sacrificed after 8 weeks and Control 12wks: sacrificed after 12 weeks). DM groups 
(n=15) received single i.v. injection of STZ (STZ, Sigma–Aldrich, St. Louis, MO, USA) dissolved 
in sodium citrate 0.1ml buffer, PH 4.5 at a dose of 60 mg/kg [2]. This group was subdivided into 3 
subgroups (n=5/subgroup) [20]: (4wks DM: sacrificed after 4 weeks, 8wks DM: sacrificed after 8 
weeks, and 12wks DM: sacrificed after 12 weeks). Fasting blood glucose levels were measured in 
DM groups (using spectrophotometer-Beckman; USA) 72 h after STZ injection to confirm 
induction of DM (>200 mg/dL). This day was considered the first day of the experiment. DM+ 
MSCs group (n=10) received single i.v. dose of STZ and 4 weeks later a single i.v. dose of 
fluorescent MSCs 1 ml of about 2,000,000 stem cells in the rat tail vein [15]. This group was 
subdivided into two subgroups (n=5/subgroup) [20]: (DM+MSCs 8wks: sacrificed after 8 weeks 
from the start of experiment; 4wks after MSCs administration and DM+MSCs 12wks: sacrificed 
after 12 weeks from the start of experiment; 8wks after MSCs administration). Fasting blood 
glucose levels were measured in DM and MSCs groups before sacrificed. 
Morris Water Maze (MWM): Learning and memory impairment induced by DM and 
improvement after MSCs treatment were evaluated through performing MWM (4, 8 and 12 weeks 
from the start of the experiment). It was performed according to previous studies Vorhees [32]. 
Four-day training (twice/day) learning and memory was assessed through measuring escape 
latency to rich hidden platform (recorded with video camera). The maze was structured of white 
circle tank (diameter: 127 cm and height: 51cm) filled with water depth 45 cm (made opaque with 
liquid milk) and a white platform (12 cm²) submerged 2 cm below the water surface in the 
northwest quadrant of the maze. Navigational landmarks in the form of external cues were placed 
to the room wall. Signs of retrieving such memory (by removing platform and animals were 
allowed to swim freely for 60 seconds) were assessed through a provisional trial by counting both 
the number of platform-site crossovers and percentage of time spent in the target quadrant 
compared with the other quadrants. Statistical analysis was done for the means of escape latency 
times/secs of the trails; and for the provisional trial. 
Scarification and Histological staining: By the end of the experimental periods, animals 
were anaesthetized by I.V. injection of Ketamine-dylazine and cardiac perfusion fixation 
technique by formalin 10% was done. For brain extraction, animals were decapitated immediately 
rostral to the first cervical vertebra and brains were removed. The right hemispheres allocated for 
light microscopic examination stained with Hx. & E. Studying hippocampal both CA1 and CA3 
regions, as those regions are the hub of memory and learning functions [18]. The left hippocampi 
were dissected and allocated for ultrastructural examination using transmission electron 
microscope JEOL TEM (JEM-1400, JEOL, Japan) at 80 kV. To detect labeled MSCs in the 
hippocampus, 2 sections of both MSCs subgroups were immunostained by anti-Brdu and goat 
anti-mouse Ig and examined by fluorescent microscopy (Fig 1).  
Morphometric analysis: It was conducted by using hippocampal histological sections 
stained by Hx.& E., implemented for the numbers of the pyramidal neurons in CA1 and CA3 
hippocampal regions in all subgroups (five sections par each) using total magnification of 400. 
These statistical assessments were performed using analysis of variance (ANOVA) and statistical 
package for social science (SPSS).  P value > 0.05 was considered not significant (NS) and P 
value <0.05 was considered significant (S). 
 
Results  
Statistical analysis 
Regarding to the escape latency parameter in MWM test, all control groups showed identical 
numerical data so they are considered as one control group. All DM subgroups tended to require 
significant more escape latency periods to find platform than control group and there was more 
significant difference between 12wks DM than after 8wks DM subgroups (P<0.05) (Fig 2a). On 
the other hand, MSCs treatment improved learning and memory deficit, as both MSCs subgroups 
exhibited a significant decrease in the escape latency period (P<0.05) as compared to DM 
subgroups (Fig 2a) but still significantly higher numbers when compared to control groups (P< 
0.05) (Fig 2a). Evaluation of provisional trial test, the mean numbers of the DM subgroups 
showed significantly lower numbers compared to control groups (P< 0.05). However, the 
outcomes of DM+MSCs subgroups were significantly improved when compared to DM 
subgroups but still lower than control groups (P< 0.05) (Fig 2b).  
Concerning fasting blood glucose levels in all groups, the mean numbers were significantly 
increased in DM groups according to the extent of diabetic durations (P<0.05) but with MSCs 
treatment the numbers were significantly decreased according to the extent of treatment indicating 
improvement (P<0.05) (Table 1).   
Control groups 4wks DM 8wks DM 12wks DM DM+MSCs 
8wks 
DM+MSCs 
12wks 
82.7±5.65 224±6.91 248.5±35.08 273±13.93 134.5±22.59 117±7.91 
 
Table (1): the mean numbers of fasting blood glucose level (mg/dl) in all groups 
Regarding to the morphometrical statistical analyses of the pyramidal neurons mean numbers 
were used to assess diabetic neuronal degeneration and regeneration by MSCs of CA1and CA3 
regions. 
The numbers of both regions of DM subgroups were decreased when compared to control 
group. Pyramidal cell reduction of CA3 was significant in 8wks and 12 wks DM subgroups while 
the reduction of number of cells of CA1 was only significant in12wks DM subgroup (P< 0.05). 
Moreover, among DM subgroups, their mean numbers were decreased according to the extent of 
DM duration; this reduction was significant in rats of 12wks DM subgroup (P< 0.05). There was 
prominent neuronal numbers improvement in DM+MSCs subgroups. However, the numbers were 
still significantly lower in DM+MSCs 8wks subgroup when compared to control group (P<0.05). 
On the other hand, marked improvement in their numbers was demonstrated in rats of DM+MSCs 
12wks subgroup which was non-significant in CA1 region and only significant in CA3 region 
when compared to the control group (P>0.05) (Fig 3). 
 
Haematoxylin and Eosin stained sections:  
All control groups showed identical histological architecture, so they were considered as 
one control group.  
Examination of CA1 region: The control group revealed arranged pyramidal neurons of 
uniform size and shape with narrow neuropil in-between, each enclosing single, rounded, large 
and vesicular nucleus with prominent nucleolus. Many glial cells within the molecular layer were 
seen (Fig 4a). On examination of 4wks DM subgroup; most of the pyramidal neurons were 
comparable to the control, while other few neurons were shrunken with karyorrhectic  and 
karyolytic nuclei. vacuolations were also seen (Fig 4b). On examination of the 8 wks DM 
subgroup showed more neuronal damage as many neurons had clogged marginated chromatin or 
hyperchomatic neurons (Fig 4c). Moreover, on examination of 12wks DM subgroup exhibited 
severe damage as apparent losses of the neuronal regularity; many shrunken hyperchromatic 
nuclei and severe clumping of the neuronal processes (Fig 4d). On the other hand on examination 
of DM+MSCs 8wks, there were variable degrees of improvement as neurons seemed normal 
comparable to the control, relatively few shrunken nuclei with vacuolated cytoplasm and small 
areas with clumping neuronal processes (Fig 4e).  Moreover, examination of DM+MSCs 12wks 
demonstrated more improvement as increased population of pyramidal neurons with apparent 
compact and regular distribution, few shrunken neurons with hyperchromatic nuclei (Fig 4f). 
Examination of CA3 region: The control group revealed arranged layers of pyramidal 
neurons represented with vesicular nuclei, well-formed basophilic cytoplasmic Nissl granules 
surrounded by narrow neuropil. The molecular layer showed glial cells (Fig 5a). However in 4wks 
DM subgroup; the pyramidal neurons represented normal nuclear appearance, while few nuclei 
with clogged marginated chromatin, relatively few shrunken neurons with vacuolated cytoplasm 
or with peripheral karyorrhectic nuclei and narrow neuropil with few vacuolations (Fig 5b). 
Moreover, on examination of 8wks DM subgroup there were pleopathological changes; as 
pyramidal neurons were haphazardly arranged with many pyknotic nuclei, neurons with peripheral 
homogenous nucleus and severe vacuolation with clumping processes (Fig 5c). Also, the 12wks 
DM subgroup represented more degeneration as neuronal disorganization with eosinophilic 
vacuolated cytoplasm and severe clumping processes (Fig 5d). While on examination of 
DM+MSCs 8wks subgroup, there were minimal regeneration as pyramidal neurons showed 
normal appearance and almost normal neuropil comparable to control group. However, others 
were represented with karyorrlytic or pyknotic nuclei and vacuolated cytoplasm. Extraneuron 
amyloid deposition was noticed (Fig 5e). Additionally, DM+MSCs 12wks subgroup had 
regeneration signs as most of the pyramidal neurons were comparable to control with vesicular 
nuclei. Only few shrunken neurons represented with hyperchromatic nucleus and areas devoid of 
neurons were seen (Fig 5f). 
Ultrastructural study of the pyramidal neurons:  
The control groups revealed the normal neuronal ultrastructure; intact cell membrane, 
intact cytoplasmic mitochondria with normal cristae. Euchromatic nucleus with smooth nuclear 
envelope consisting of bilaminar layers and well-formed nuclear pores were seen (Fig 6a). On the 
other hand, the pyramidal neurons of 4wks DM subgroup showed dense neuron form with 
irregular out line, ballooning mitochondria with disrupted cristae and cytoplasmic deposition of 
electron-dense bodies. The nucleus showed rounded and distinctly chromatin clumps (Fig 6b).  
Pyramidal neurons of 8wks DM subgroup had more degeneration as nuclear condensation, 
ballooned mitochondria and more cytoplasmic lipofuscin particles (Fig 6c). Additionally, 
pyramidal neurons of 12wks DM subgroup had severe degeneration signs as apoptotic changes as 
nuclear membrane indentation, cytoplasmic condensation, few neurons with highly condensed 
dense chromatin and vacuolations within the neuropil (Fig 6d). While on examination of 
pyramidal neurons of DM+MSCs 8wks subgroup, there were some regeneration as normal 
neuronal form with euchromatic, central, and rounded nuclei. But few cells had abnormal dense 
form with shrunken and electron dense nuclei (Fig 6e). Moreover, pyramidal neurons of 
DM+MSCs 12wks subgroup, there was more regeneration as normal neuronal ultrastructure with 
intact mitochondria (Fig 6f). 
 
Discussion 
DM is a common serious metabolic disease and usually associated with cerebral 
alternations [31]. Several studies indicated that DM negatively affects hippocampal cellular 
morphology, proliferation and survival, indicating function impairment of this brain region [35]. 
MSCs treatment had been shown as a promising modality in the treatment of the injured brain 
[11], beside that there were contradictions concerning the differention of MSCs into the 
functioning nerve cells. In the present study, the MWM results of DM subgroups indicating 
learning and memory impairment which become worst with prolonged durations. Similar results 
were obtained by Malone [23] who further explained that DM decreased hippocampal 
neurotransmitters release; presynaptic synaptophysin and postsynaptic density protein which are 
the cause of memory and learning deficiency. However in MSCs treated subgroups, there was 
prominent functional improvement which got better with prolonged treatment duration, indicating 
progressive improvement of neuronal function. These results were agreement with the findings of 
Chen [5] who detected that MSCs increase production of neorotrophic factors and enhancing 
neuronal plasticity of the injured brain.  
Alongside with these functional impairment and improvements, the histological and 
ultrastructural examination showed hippocampal degenerative changes accompanying DM were 
variable regarding the affected region and also related to the duration of DM exposure. Minor 
apoptotic alternations were detected in 4wks DM subgroup in both CA1and CA3 regions, in 
agreement with findings Zhao [36] who study CA1 and dentate gyrus.  But, more changes were 
mainly seen in CA3 region of 8 wks DM subgroup concurring to findings of Jafari [12], Kamal 
[14].  Furthermore, when DM was prolonged for 12 wks, progressive changes consequences were 
demonstrated mainly in CA3 region. These results were in harmony with findings of long-term 
study of Yang [33].  
These apoptotic degenerative changes were confirmed by more accurate statistical 
morphometric data as all DM subgroups showed reduction of number of pyramidal neurons which 
was more significant in 12 wks than 4 wks and 8 wks indicating the progressive degenerative 
changes. 
The findings of earlier diabetic neuronal apoptotic changes detected in the current work 
were explained by Zhao [36] and Orlovsky [27] as excessive production of nitric oxide in the 
hippocampal areas which has neurotoxic effect inducing neuronal damage and apoptosis. Also, the 
findings of progressive diabetic neuronal apoptotic changes were further explained by Yang [33] 
who established that long-term DM induces oxidative stress and lipid peroxidation with 
impairment of membrane functions. This occurs through decreasing membrane fluidity and 
changing the activity of membrane-bound enzymes and receptors. Additionally, Li [19] clarified 
neuronal cells' apoptosis, as diabetic hyperglycemia leads to opening of mitochondrial 
permeability transition pores which directs up expression of caspase 3 and caspase 8 that play a 
central role in the execution-phase of cell apoptosis.  
Seeking for MSCs possible improving role, fluorescent-labeled MSCs were recognized in 
the hippocampus after their systemic injection according to each DM+MSCs subgroups. In the 
current work, the histological and ultrastructural examination of MSCs treated subgroups showed 
variable amelioration of the pathological changes and increase of neuronal numbers regarding the 
extent of MSCs treatment and degree of damage produced by DM on the hippocampus. MSCs 
treatment for 4 wks after 4 wks of diabetic neuronal damage led to improvement of apoptotic 
changes especially more in CA1 region than in CA3 region. Moreover, this improvement was 
more apparent with prolonged duration of MSCs treatment to 8 wks after 4 wks of diabetic 
neuronal damage. There was obvious regression of neuronal apoptotic changes of CA1 and CA3 
with relatively normal pyramidal neuronal structure.  
Those histological changes were further documented by the statistical analysis of the 
morphometric counting of pyramidal neurons of both regions. There were increase in neuronal 
numbers especially with prolonged MSCs treatment in both regions, but this increase was still 
lower than control numbers. In the reviewed literatures, no studies examined the effect of i.v. 
MSCs administration on hippocampal neuronal diabetic degeneration. However, the MSCs 
neuronal improvement of CA1 region for short duration in the current work corresponds to 
findings reported by Kumar [16] who studied cold stress as a cause of hippocampal neuronal 
degeneration. Also, the improvement for longer duration of MSCs treatment was supported by the 
results obtained by Ye [34] who studied the neuronal degeneration in Parkinson disease, as there 
was neuronal recovery after 10 weeks of MSCs transplantation. While, the moderate improvement 
observed in the current work in CA3 region was in harmony with the findings of Matchynski-
Franks [24] who studied MSCs effect after 10 weeks of transplantation in a mouse model of 
Alzheimer's disease.  
Discussing the improving role of MSCs in the current study to ameliorate diabetic 
neuronal degeneration and functional impairment, many authors explained their effects in the 
injured brain; Mezey [25] concluded that human MSCs could enter the human and rat brains and 
generating neurons especially in the hippocampus and cerebral cortex. Moreover, Zhang [35] 
found that transplanted MSCs could engraft into brain tissue and differentiate in vivo into neurons 
and glial cells. In contradiction, Sanchez-Ramos [30] described that a small proportion of MSCs 
derived cells differentiated into neuron-like cells. Those findings explained by Crigler [7] and 
Munoz [26] as MSCs implantation into the hippocampus did not proliferate, but they greatly 
increased proliferation, migration and differentiation of the endogenous neuronal stem cells after 
eight weeks of neuronal degeneration. Prockop [28] described that MSCs could promote the 
neurogenesis of primary neural progenitors and survival of neural cells by expressing neurotrophic 
factors. Also, Calió [4] reported that MSCs could decrease neuronal oxidative stress and apoptosis 
changes by enhancing the anti-apoptotic activity and antioxidant protection.  These results were 
very promising for the development of a new therapeutic strategy for patient exhibiting diabetic 
neuronal degeneration and learning and memory impairment by using MSCs treatment.  
Conclusions  
MSCs administration ameliorates diabetic neuronal degeneration and learning and memory 
impairment mainly through promoting neurogenesis, alleviating oxidative stress and also through 
its anti-apoptotic effects. So, bone marrow derived MSCs treatment may exert a successful 
curative role in patients suffering from diabetic neuronal complications and improving their 
quality of life. 
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Figure 1. Hippocampal fluorescent-labeled MSCs, immunostained with BrdU antibody in: a: 
DM+MSCs 8wks group and b: DM+MSCs 12wks group Bar= 50μm. 
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Figure 2. A. The means of escape latency periods during all MWM training trials in all 
subgroups; B. The provisional trial results (the mean numbers of the platform-sites crossovers and 
the percentage of time spent in the target quadrant) in all subgroups. 
  
Figure 3. The mean numbers of the pyramidal neurons in regions (CA1 and CA2) in all 
subgroups. 
 
Figure 4. CA1 region a: control group: arranged pyramidal (P) with vesicular nucleus (thick 
arrows) and glial cells (thin arrows) in molecular layer (M). b: 4wks DM: karyorrhectic  (thick 
arrows), karyolytic (zigzag arrow) and shrinkage nuclei (thin arrows), vacuolations (arrowheads). 
c: 8wks DM: clogged marginated chromatin (arrows) and hyperchomatic neurons (curved arrows) 
in molecular layer (M). d: 12wks DM: severe degeneration as, many shrunken nuclei (arrows) and 
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clumping neuronal processes (arrowheads). e: DM+MSCs 8wks: neuronal improvement (thick 
arrows), few shrunken nuclei (curved arrows) and clumping processes (asterisk). f: DM+MSCs 
12wks:  progressive neuronal improvement (thick arrows), few shrunken neurons (thin arrows) 
Bar= 50μm. 
 
Figure 5. CA3 region a: control group: arranged pyramidal neurons (thick arrows), well-formed 
Nissl granules (arrowheads) and glial cells (thin arrows) in the molecular layer (M). b: 4wks DM: 
clogged marginated nuclear chromatin (curved arrows), karyorrhectic  nuclei (zigzag arrows), 
vacuolated cytoplasm (thin arrows) and neuropil vacuolations (arrowheads).  c: 8wks DM: 
pyknotic nuclei (thin arrows), neuron with homogenous nucleus (thick arrow) and clumped 
processes (arrowheads). d: 12wks DM: more degeneration as eosinophilic cytoplasm (thick 
arrows) and clumping processes (arrowheads). e: DM+MSCs 8wks: minimal regeneration as 
neuronal vesicular nuclei (thick arrows), karyorrlysis (thin arrows) or pyknotic nuclei (curved 
arrows) and amyloid depositions (A). f: DM +MSCs 12wks: more regeneration as pyramidal 
neurons with vesicular nuclei (thick arrows), areas devoid of neurons (asterisks) and few shrunken 
neurons (thin arrows) Bar= 50μm 
 Figure 6. Pyramidal neurons a: control group: normal neuron with intact mitochondria 
(arrowheads), lysosomes (zigzag arrow), euchromatic nucleus (N), smooth envelope (thin arrow) 
and well-formed nuclear pores (thick arrow) Bar= 2μm. b: 4wks DM subgroup: irregular neuronal 
out line (zigzag arrow), ballooning mitochondria (arrowheads), electron-dense body (thick arrow), 
the nucleus (N) with chromatin clumps (thin arrow) Bar= 2μm. c: 8wks DM subgroup: more 
degeneration as nuclear condensation (N), many ballooning mitochondria (arrowheads) Bar= 2μm. 
d: 12wks DM subgroup: severe degeneration as condensation with membrane indentation (thin 
arrow), highly condensed dense chromatin neuron (thick arrow) and vacuolations (V) Bar= 2μm. 
e: DM+MSCs 8wks subgroup: some regeneration as normal neuronal form (arrowhead) with 
euchromatic nucleus (N), few abnormal dense neurons (arrow) Bar= 2μm. f: DM+MSCs 12wks 
subgroup: more regeneration as normal neuronal ultra-structures with intact mitochondria (arrow) 
Bar= 2μm 
 
